Prednisolone Tablets Articles
Taro files ANDA to challenge S-P's Claritin
6 August 2001
Indian price moves for 45 formulations
23 January 2001
S-P files for new desloratadine formulations
14 December 2000
Aventis seeks buyer for stake in R-P India
28 November 2000
Latest approvals from Japan's advisory board
25 October 2000
Indian malaria, asthma/ allergy price moves
10 October 2000
India's NPPA slashes 36 formulation prices
16 June 2000
Indian NPPA imposes drug price changes
23 May 2000
Dutch OTC industry calls for self-selection
10 December 1999
Sincere Pharma set up in China's Jiangsu
7 December 1999
State of development in Ono Pharma R&D pipeline
10 November 1999
Vietnamese pharma prices and imports down
11 October 1999
India revises the prices of 16 drug products
30 September 1999
Film/TV placement for cough/cold OTCs
23 September 1999
JB Chemicals selling ayurvedic cough syrup
28 July 1999
Parke Davis India reports profit fall
5 July 1999
Alizyme to trial obesity drug next year
27 April 1999
Alizyme starts Phase I trials
31 March 1999
Schering-Plough sues Copley over Claritin
29 March 1999
Japan's Ono Pharma Highlights R&D Pipeline
28 October 1998
Pediatric Versed Approved In USA
22 October 1998
Prednisolone Farnesylate Launch In Japan
23 September 1998
Levalbuterol Nears Approval In USA
7 July 1998
Asta Comes Through Tough Year, Looks To Expansion
4 March 1998
Australia Excludes SSRIs From Final TGP Scheme
17 December 1997
Phase III Results With Novartis' Basiliximab
29 October 1997
GW's Zantac Knocked Off Top US Rx Drug Spot
4 September 1997
Clinton Plans New Rules On Child Drug Safety
19 August 1997
Investors Impressed With Glaxo Wellcome Pipeline
12 May 1997
Rhone-Poulenc Reorganizes In India
7 April 1997
Orphan Drug Designations In Japan
7 April 1997
New CPAC Approvals Include Two NCEs
7 April 1997
Generic Ditropan From Morton
19 March 1997
Astra's Entocort: Update
17 March 1997
Celltech's CDP571 Shows Promise In Crohn's
3 March 1997
WHO Warns On False Medicines "Ravaging World Markets"
11 November 1996
S-P's Claritin Syrup Approved In USA
28 October 1996
African Fake Vaccines Debacle Hits Merieux, SB
2 September 1996
Go-Ahead For Generic Albuterol In USA
8 January 1996
MSD Launch
24 April 1995
Astra Files For Entocort Capsules In UK
13 March 1995
French drug Market "Will Decline 2%-4% This Year"
23 January 1995
Alcon's Vexol Approved In USA
9 January 1995
MDR: Misunderstood Drug Resistance?
5 December 1994
Schering Launches Fludara In UK
31 October 1994
Budesonide Effective In Crohn's Disease
3 October 1994
Child-Resistant Containers In The UK
15 August 1994
Panel Backs Indication Extension For Retrovir
8 August 1994
MYOTROPHIN TESTED FOR POST-POLIO SYNDROME
16 May 1994
PHARMOS: AN EYE FOR A PRODUCT TARGET
2 May 1994
MORE ON NETIVUDINE WITHDRAWAL
4 April 1994
CANADA OTC COUGH/ COLD SALES BOOM
21 March 1994
UCB INTRODUCES DRINKABLE FORMUALTION OF ZIRTEK
21 February 1994
POSSIBLE INFLUENZA TREATMENT
24 January 1994
LILLY REBUKED OVER FIALURIDINE DEATHS
20 December 1993
AL LABS RECEIVES APPROVAL
6 December 1993
103% NET INCOME RISE FOR ISRAEL's TEVA
22 November 1993
NIGERIAN COMPANIES SHOW GOOD PROGRESS
1 November 1993
NIKKEN LAUNCH
25 October 1993
SANDOZ SETTLES CHARGES
12 July 1993
KASEI DEAL WITH TANABE
26 April 1993
UNLICENSING drugs AND OFF-LABEL PRESCRIBING
14 December 1992
ANTIBODY THERAPY FOR ARTHRITIS: PHASE I STUDY
5 October 1992
TEVA TO SIGN ACQUISITION DEAL
7 September 1992
CHANGES IN ISRAELI DRUG COSTS TO CONSUMERS
11 May 1992
TEVA'S GENERIC BRONCHODILATOR
20 April 1992
NORTH AMERICA'S OTC COUGH COLD MARKET
9 March 1992
CHEMOTHERAPY STUDY
3 February 1992
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
